CHOLEBRINE Drug Patent Profile
✉ Email this page to a colleague
When do Cholebrine patents expire, and what generic alternatives are available?
Cholebrine is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in CHOLEBRINE is iocetamic acid. Additional details are available on the iocetamic acid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHOLEBRINE?
- What are the global sales for CHOLEBRINE?
- What is Average Wholesale Price for CHOLEBRINE?
Summary for CHOLEBRINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Patent Applications: | 820 |
| DailyMed Link: | CHOLEBRINE at DailyMed |
US Patents and Regulatory Information for CHOLEBRINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | CHOLEBRINE | iocetamic acid | TABLET;ORAL | 017129-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
